live attenuated vaccine | sciencenewsnet.in

Breaking News

Hackensack Meridian Pascack Valley Medical Center Earns An ‘A’ Hospital Safety Grade from The Leapfrog Group

Keck Hospital of USC earns an ‘A’ Hospital Safety Grade from The Leapfrog Group

Hackensack Meridian Mountainside Medical Center Nurse Wins Research Award at ACC Quality Summit

Breakthrough Idea for CCU Technology Commercialization from ‘Carbon Cycle of the Earth’

Launch of nationwide map viewer and database aids wildfire planning and understanding of treatment effects

Scientists Gain New Insights into How Mass Is Distributed in Hadrons

MSU expert: What the history of lame-duck presidents can tell us about President Biden’s final actions

Helping Soldiers Serve on a Full Stomach

UNC’s Graduate School Waives Application Fee for Current Students and Alumni

Addressing Food Insecurity on Campus with Expanded Resources

15 Nov, 2024

Texas Biomed HIV vaccine candidate aims to block virus before it takes root

February 15, 2023 sarah JonasAnnouncement

The National Institutes of Health has awarded $3.8 million to Texas Biomedical Research Institute to further develop a promising HIV vaccine candidate that stops the virus upon entry, before it begins rapidly spreading throughout the body.

Scientists develop effective intranasal mumps-based COVID-19 vaccine candidate

July 27, 2022 sarah JonasResearch Results

New research has advanced COVID-19 vaccine work in several ways: using a modified live attenuated mumps virus for delivery, showing that a more stable coronavirus spike protein stimulates a stronger immune response, and suggesting a dose up the nose has an advantage over a shot.